In case you missed it, the Pharmaceutical Care Management Association (PCMA) released a new Rx Research Corner blog, by Vice President of Research Amanda Frost, that quantifies what a world without pharmacy benefit companies would look like for employers and
A recent white paper (“The Association Between Drug Rebates and List Prices”) narrowly suggests an association between list prices for brand drugs and the rebate practices of pharmacy benefit managers (PBMs) and insurers, despite an underlying methodology that is notably broader
The Value of Pharmacy Benefit Management PBMs Create $145 Billion in Value Annually Groundbreaking research by University of Chicago Economics Professor Casey Mulligan describes the services that pharmacy benefit managers (PBMs) provide in the healthcare marketplace to patients, health plans,
If Drug Companies Had Their Way… There Would Be No Check on Their Power Download Infographic Patients Would Pay List Price for Drugs Drug companies often raise list prices annually in January and July. In January 2021, 822 brand drugs
Upcoming Events Events 10 Nov 10 Nov – 11 Nov Test 2021-11-10 01:00 AM – 2021-11-11 03:00 AM Online Event PCMA Spring Webinar Series 2020 The live webinar series is designed to highlight drug supply chain executives’ thoughts and strategies
A World Without Pharmacy Benefit Companies… …Means Employers Would Have to Go it Alone Pharmacy benefit companies play an important and unique role in the drug supply and payment chain. While they are best known for lowering drug costs through
©2024 PCMA. All Rights Reserved.
